Intelligent Bio SolutionsINBS
13F holders, Q1 2026 (March 31)9holders +2
4new positions
4sold out
$3.35avg. 13F price*
At the end of Q1 2026, 9 institutions reported holding Intelligent Bio Solutions Inc. (INBS) in their 13F filings, up 2 from Q4 2025. 4 opened new positions and 4 sold out. The largest holders were Armistice Capital, LLC ($435K), Alyeska Investment Group, L.P. ($127K) and Geode Capital Management, LLC ($96K).
- Company
- Intelligent Bio Solutions Inc.
- CUSIP
- 36151G709
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $658K |
| Exits | 4 | $1K |
All 13F filers, Q4 2025 → Q1 2026: 196,765 shares bought and 3,837 shares sold, net +192,928 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Armistice Capital, LLC | 0.01% | New | 130,000 | $435K |
| Alyeska Investment Group, L.P. | 0.00% | New | 37,956 | $127K |
| Geode Capital Management, LLC | 0.00% | New | 28,609 | $96K |
| Vanguard Capital Management LLC | 0.00% | — | 5,810 | $19K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 3,958 | $13K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.8% | 1,250 | $4K |
| UBS Group AG | 0.00% | Reduce -90.8% | 372 | $1K |
| Osaic Holdings, Inc. | 0.00% | New | 200 | $670 |
| Curio Wealth, LLC | 0.00% | No change | 200 | $669 |
"% of holder's portfolio" is INBS's weight in each manager's 13F, not the share of Intelligent Bio Solutions Inc. the manager owns.